Tumor-targeted Drug Delivery by Nanocomposites

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Conventional tumor-targeted nanoparticle delivery faces challenges due to tumor complexity and design limitations.
• Enhanced permeability and retention (EPR) effect and receptor-mediated endocytosis are traditional but demanding approaches.
• Biological and natural complications of tumors restrict the design of accurate nanoparticle delivery systems.

Purpose of the Study:

• To review triggered multistage drug delivery systems (MSDDS) for tumor therapy and imaging.
• To explore how tumor environment stimuli can be utilized for advanced drug delivery.
• To elaborate on the function, effects, and diagnosis of multi-stimuli sensitive nanoparticle systems.

Main Methods:

• Utilizing different tumor environment stimuli to trigger multistage drug delivery.
• Designing MSDDS that adapt physicochemical properties (size, hydrophobicity) to the tumor microenvironment.
• Achieving tumor penetration, enhanced cellular uptake, controlled drug release, and endosomal escape.

Main Results:

• MSDDS enable maximum drug delivery to target therapeutic cells, tumor tissues, and subcellular organisms.
• Nanoparticle formulations effectively resolve issues of poorly soluble compounds and poor bioavailability.
• The systems demonstrate improved drug targeting and therapeutic efficacy.

Conclusions:

• Smart MSDDS utilize multi-stimuli sensitive nanoparticle systems for targeted tumor therapy.
• Understanding tumor environment stimuli is key to developing effective nanoparticle drug delivery.
• These systems offer a promising approach for overcoming drug delivery challenges in cancer treatment.